These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 694638)

  • 21. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.
    Dennerstein GJ
    J Reprod Med; 1986 Sep; 31(9):801-3. PubMed ID: 2945926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medroxyprogesterone acetate as an injectable contraceptive.
    Heber KR
    Aust Fam Physician; 1988 Mar; 17(3):199-201, 204. PubMed ID: 2965570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of Depo Provera as a contraceptive in the puerperium].
    Narducci U; Piatti N
    Minerva Ginecol; 1973 Feb; 25(2):107-11. PubMed ID: 4735312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contraception with a six-monthly injection of progestogen. 1. Effects on blood pressure, body weight and uterine bleeding pattern, side-effects, efficacy, and acceptability.
    Mackay EV; Khoo SK; Adam RR
    Aust N Z J Obstet Gynaecol; 1971 Aug; 11(3):148-56. PubMed ID: 5286756
    [No Abstract]   [Full Text] [Related]  

  • 25. Contraceptive efficacy and safety of DMPA-SC.
    Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
    Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with Cyclo-Provera, a parenteral monthly contraceptive. Preliminary report].
    Rubio Lotvin B; Ruíz Moreno JA; Bolio Arista R; Gónzalez Ansorena R
    Prensa Med Mex; 1974; 39(1-2):48-50. PubMed ID: 4420202
    [No Abstract]   [Full Text] [Related]  

  • 27. Body weight and bleeding pattern changes in women using DMPA-SC.
    Chaudhri R; Rizvi F; Afzal M
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):618-21. PubMed ID: 19811711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera.
    Jain J; Dutton C; Nicosia A; Wajszczuk C; Bode FR; Mishell DR
    Contraception; 2004 Jul; 70(1):11-8. PubMed ID: 15208047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medroxyprogesterone acetate administered intramuscularly every third month as a contraceptive. An investigation of the efficacy, side effects and acceptability].
    Marker IL
    Ugeskr Laeger; 1973 Feb; 135(6):294-7. PubMed ID: 4690434
    [No Abstract]   [Full Text] [Related]  

  • 30. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC
    Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-monthly Depo-Provera in Mexico.
    Correu Azcona S
    IPPF Med Bull; 1977 Jun; 11(3):2-3. PubMed ID: 12335212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ask the experts: progestin-only contraceptives.
    Hatcher RA; Schnare S
    Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects.
    Basnayake S; Thapa S
    Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience with contraceptive effect of Depo-Provera, 300mg and 450mg, administered in 6-month intervals].
    Havránek F; Tichý M; Divila F; Hejda V
    Cesk Gynekol; 1972 Mar; 37(2):95-6. PubMed ID: 5023983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injectable and implantable contraceptives.
    Cullins VE
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depo-provera: contraceptive risk?
    Rosenfield A
    Hastings Cent Rep; 1980 Apr; 10(2):4. PubMed ID: 6445344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment counseling keeps patients on Depo.
    Contracept Technol Update; 1997 Oct; 18(10):125-6. PubMed ID: 12321212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.